BEGIN:VCALENDAR PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN VERSION:2.0 BEGIN:VEVENT DESCRIPTION:Delivering Oligonucleotides with Specificity\, Mitigating Off- Target Effects\, and Improving Cellular Uptake to Target Undruggable Mole cules.\n\nThe Oligonucleotide-based Therapeutics Summit is uniting leader s in RNA chemistry\, delivery science\, and translational biology to adva nce oligonucleotides as a pioneering therapeutic class.\n\nWith multiple approvals\, growing clinical validation across diverse indications\, and breakthroughs in chemical modifications and delivery platforms\, oligonuc leotides are no longer a niche field\, they’re rapidly becoming the modal ity of choice for tackling both validated and previously “undruggable” ta rgets. The question is no longer if oligonucleotides will reshape the the rapeutic landscape\, but how fast.\n\nThis December in Boston\, unite wit h leading experts from Secarna\, Genentech\, Avidity Bioscience\, Dyne Th erapeutics\, Biogen\, Novo Nordisk\, Stoke Therapeutics\, and more as the y reveal cutting-edge insights spanning discovery to late-stage developme nt. Discover how advances in RNA chemistry and delivery are unlocking saf er\, more precise therapies\, broadening therapeutic potential\, and driv ing faster patient impact. Don’t miss the only meeting dedicated exclusiv ely to unlocking the full therapeutic potential of oligonucleotides.\n\n& nbsp\;\n\nURLs:Tickets: https://go.evvnt.com/3247806-2?pid=185 \;Broc hure: https://go.evvnt.com/3247806-3?pid=185 \;\n\nDate and Time: Tue \, 09 Dec 2025 08:00 - Thu\, 11 Dec 2025 17:00\n\nVenue details: Hotel Co mmonwealth\, 500 Commonwealth Avenue\, Boston\, Massachusetts\, 02215\, U nited States\n\nCategory: Conferences | Science\, Health &\; Medicine | Pharmaceuticals\n\nPrices:Drug Developer Pricing - Conference + Pre-Con ference Workshop Day: USD 4197.00\,Drug Developer Pricing - Conference On ly: USD 2999.00\,Academic and Not-for-Profit Organizations - Conference + Pre-Conference Workshop Day: USD 3597.00\,Academic and Not-for-Profit Or ganizations - Conference Only: USD 2599.00\,Service and Solution Provider s - Conference + Pre-Conference Workshop Day: USD 5097.00\,Service and So lution Providers - Conference Only: USD 3699.00\n\nSpeakers: Cody Desjard ins\, Senior Director\, Dyne Therapeutics\, David Guay\, Vice President\, Innovation and Technology\, Feldan Therapeutics\, David Parfitt\, Senior Scientist\, ProQR Therapeutics\, Frank Jaschinski\, Chief Scientific Off icer\, Secarna\, Ganesh Iyer\, Chief Executive Officer and Founder\, Oppr tna Therapeutics\, HAGEN Cramer\, Chief Technology Officer\, QurAlis\, Ja ce Jones\, Associate Professor\, University of Maryland\, Jack Ostrowski Director\, Protein Sciences\, Avidity Biosciences\, Jean-Christophe Hofla ck\, Senior Principal Scientist\, F Hoffmann-La Roche\, Kevin Guckian\, S enior Director\, Biogen\, Marcin Kortylewski Professor\, City of Hope\, M eena Indrakanti Senior Vice President\, Translational Drug Metabolism\, P harmacokinetics and Clinical Pharmacology\, Stoke Therapeutics\, Michael Cummings\, Professor\, University of Maryland\, Paloma Giangrande\, Senio r Vice President of Discovery and Translational Biology\, Orbital Therape utic\, Pawan Kumar Director\, Oligonucleotide Chemistry\, Biomarin\, Pune et Anand\, PhD\, Regeneron\, Santhosh Kumar\, Thatikonda Senior Principal Scientist\, Genentech\, Tama Evron Director\, Platform Discovery\, Dyne Therapeutics\, Utsav Saxena\, Head of Systems Biology\, Novo Nordisk\n DTEND:20251211T170000 DTSTAMP:20260512T223118Z DTSTART:20251209T080000 LOCATION:Hotel Commonwealth\, 500 Commonwealth Avenue \, Boston\, Massach usetts\, 02215\, SEQUENCE:0 SUMMARY:Delivering Oligonucleotides with Specificity\, Mitigating Off-Targ et Effects\, and Improving Cellular Uptake to Target Undruggable Molecule s.\nThe Ol... UID:a3b2340b-8f6e-4f54-a8c5-4a1c495ef2c7 END:VEVENT END:VCALENDAR